- Home
- FLXS vs TVRD Comparison
FLXS vs TVRD Comparison
Compare FLXS & TVRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLXS
- TVRD
- Stock Information
- Founded
- FLXS 2001
- TVRD 2017
- Country
- FLXS United States
- TVRD United States
- Employees
- FLXS N/A
- TVRD N/A
- Industry
- FLXS Home Furnishings
- TVRD Biotechnology: Pharmaceutical Preparations
- Sector
- FLXS Consumer Discretionary
- TVRD Health Care
- Exchange
- FLXS Nasdaq
- TVRD Nasdaq
- Market Cap
- FLXS 250.5M
- TVRD 246.5M
- IPO Year
- FLXS N/A
- TVRD N/A
- Fundamental
- Price
- FLXS $43.45
- TVRD $39.91
- Analyst Decision
- FLXS
- TVRD Strong Buy
- Analyst Count
- FLXS 0
- TVRD 5
- Target Price
- FLXS N/A
- TVRD $59.20
- AVG Volume (30 Days)
- FLXS 30.0K
- TVRD 68.2K
- Earning Date
- FLXS 10-20-2025
- TVRD 11-21-2025
- Dividend Yield
- FLXS 1.83%
- TVRD N/A
- EPS Growth
- FLXS 85.86
- TVRD N/A
- EPS
- FLXS 3.55
- TVRD N/A
- Revenue
- FLXS $441,073,000.00
- TVRD N/A
- Revenue This Year
- FLXS $5.24
- TVRD N/A
- Revenue Next Year
- FLXS $4.50
- TVRD N/A
- P/E Ratio
- FLXS $12.30
- TVRD N/A
- Revenue Growth
- FLXS 6.86
- TVRD N/A
- 52 Week Low
- FLXS $29.38
- TVRD $8.13
- 52 Week High
- FLXS $65.87
- TVRD $42.10
- Technical
- Relative Strength Index (RSI)
- FLXS 38.15
- TVRD 68.51
- Support Level
- FLXS $44.13
- TVRD $39.44
- Resistance Level
- FLXS $45.80
- TVRD $42.10
- Average True Range (ATR)
- FLXS 1.76
- TVRD 2.65
- MACD
- FLXS -0.99
- TVRD 0.02
- Stochastic Oscillator
- FLXS 1.25
- TVRD 75.13
About FLXS Flexsteel Industries Inc.
Flexsteel Industries Inc is a United States-based company that manufactures, imports, and markets residential upholstered wooden furniture products. Its product offerings include sofas, loveseats, chairs, rockers, desks, tables, convertible bedding units, and bedroom furniture. The company's products are intended for use in home, office, hotel, healthcare, and other contract applications. A featured component in the company's upholstered furniture is the durable Blue Steel Spring. It operates in the business segment of Furniture products. The company's furniture products business involves the distribution of manufactured and imported products for residential markets.
About TVRD Tvardi Therapeutics Inc. Common Stock
Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.